Does VALSARTAN Cause Renal cell carcinoma? 64 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 64 reports of Renal cell carcinoma have been filed in association with VALSARTAN (valsartan). This represents 0.3% of all adverse event reports for VALSARTAN.
64
Reports of Renal cell carcinoma with VALSARTAN
0.3%
of all VALSARTAN reports
26
Deaths
47
Hospitalizations
How Dangerous Is Renal cell carcinoma From VALSARTAN?
Of the 64 reports, 26 (40.6%) resulted in death, 47 (73.4%) required hospitalization, and 26 (40.6%) were considered life-threatening.
Is Renal cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VALSARTAN. However, 64 reports have been filed with the FAERS database.
What Other Side Effects Does VALSARTAN Cause?
Drug ineffective (1,845)
Blood pressure increased (1,682)
Dizziness (1,527)
Headache (1,361)
Hypertension (1,341)
Acute kidney injury (1,301)
Dyspnoea (1,239)
Fatigue (1,156)
Malaise (1,139)
Hypotension (1,032)
What Other Drugs Cause Renal cell carcinoma?
CABOZANTINIB S-MALATE (451)
SUNITINIB MALATE (361)
PAZOPANIB (244)
AXITINIB (154)
RANITIDINE (143)
EVEROLIMUS (130)
SORAFENIB (118)
METHOTREXATE (116)
ADALIMUMAB (105)
PREDNISONE (101)
Which VALSARTAN Alternatives Have Lower Renal cell carcinoma Risk?
VALSARTAN vs VALTREX
VALSARTAN vs VAMOROLONE
VALSARTAN vs VANCOMYCIN
VALSARTAN vs VANDETANIB
VALSARTAN vs VARDENAFIL